Early Data Send Our Stock up 400%
There’s big risk, but there are also big rewards from working to find therapies to treat COVID-19. That’s brought biotech companies into play as they pit their experimental therapies against the coronavirus in a bid find something that helps. And one in particular is making huge strides…
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication(s) below and get access today!
Ray Blanco’s FDA Trader
Ray Blanco’s FDA Trader focuses on medical tech stocks with prices that move based on triggers generally unknown to the market. It is designed to alert you to breakout moves in the medical markets that could ultimately drive huge stock market gains. It’s the single best way to connect the dots that link today’s dynamic, innovative medical market.